Leadership Changes Analysis

FDA approves Vertex’s Journavx as first non-opioid pain drug for acute pain

FDA · moderate-to-severe acute pain · 7 min

FDA Approves Vertex’s First-in-Class Non-Opioid Pain Drug Journavx

FDA · moderate-to-severe acute pain · 8 min

Kennedy's Leadership Shakeup on Preventive Services Task Force

2 min

Latest Comings and Goings in Pharma Leadership

3 min